TOKYO, November 7, 2022—Last year, Canon Inc. acquired Redlen Technologies Inc. (Redlen), one of the world's leading companies in creating new technologies related to the development and manufacture of semiconductor detector modules¹. Canon Medical Systems Corporation (Canon Medical), a group company of Canon Inc., has developed the first domestically produced² photon-counting CT (PCCT)³ system incorporating Redlen's advanced technologies. This system has been installed at the National Cancer Center (NCC) Exploratory Oncology Research & Clinical Trial Center in Japan, where it is currently used to conduct research exploring the clinical applications of PCCT.

(Click here for details.)

1.：https://global.canon/en/news/2021/20210929.html
2.：As of November 6, 2022. Based on Canon research.
3.：Pending approval under the Pharmaceutical and Medical Device Act of Japan

Actualité | Communiqué de presse

First Domestically Produced X-ray CT System with Photon-counting Detector Installed at National Cancer Center Japan Exploratory Oncology Research ＆ Clinical Trial Center

Articles par année